Top US stocks to watch: Alphabet, Stellantis and Levi Strauss
Joshua Warner July 8, 2021 8:15 AM
Alphabet is being sued again, Stellantis hints it has performed better than expected, Levi Strauss to report later, Tesla’s latest sales figures out of China come out, Motorola could be under investigation in the UK, and Chinese firm LinkDoc is reported to have shelved its US IPO plans.
Pressure built on Alphabet yesterday as 37 US states and district attorneys sued Google and alleged it maintained its monopoly for its app store on Android phones using illegal tactics.
The states are claiming Google has been able to make ‘enormous profit margins’ from the Play Store, which acts as a portal for 90% of all apps downloaded on Android phones, using tactics such as buying-off competitors and using restrictive contracts. One claim suggests Alphabet was willing to pay Samsung not to compete in the market.
Alphabet claims the suit is about a handful of major app developers wanting preferential treatment rather than trying to aide small businesses and consumers. This builds on a number of court cases facing Alphabet in the US that threatens to disrupt its businesses across advertising, search and apps.
Carmaker Stellantis raised its expectations today after making a better start to 2021 than anticipated as improvements in prices and product mix helped boost margins.
The company said it expects a ‘very strong margin performance’ in the first half of 2021 and that it now expects to beat its 5.5% to 7.5% adjusted operating income margin over the full-year. That comes despite the shortage in semiconductors hitting the automotive industry hard in recent months. Stellantis reiterated, however, that industrial cashflows will continue to suffer from lower than expected production.
The news came ahead of its planned ‘EV Day 2021’ today, where it will unveil significant investments into electrification and connected software.
Levi Strauss, famous for its denim jeans, is due to release second-quarter results today, with analysts expecting a jump in revenue and for an improvement in earnings.
Analysts are expecting quarterly revenue to jump to $1.21 billion from just $497.5 million the year before and for the company to report diluted EPS of $0.10 compared to a $0.91 loss. Importantly, the results will be flattered as it comes up against weak comparatives from last year when the pandemic erupted and lockdowns were first introduced, causing sales to plunge and pushing it into the red.
Focus will be on the overall outlook, whether there is more clarity in Europe, and how it has performed online now that stores are open again. Notably, brokers are extremely bullish on the stock currently have an average Buy rating with a target price of $31.25.
Tesla sold 33,155 electric cars made in China in June, the vast majority of which were sold domestically, according to data from the China Passenger Car Association.
The company sold 28,138 cars in China and exported 5,017 overseas. That represents a slight fall from the 33,463 cars Chinese-made cars sold in May. Notably, Tesla launched Model Y cars in China this week and lowered its starting price for the vehicle, which could boost demand going forward.
China accounts for about one-third of Tesla’s sales and although it produced more than many domestic rivals it is still lagging behind the likes of BYD, which sold over 40,500 electric and hybrid vehicles in the period.
Tezepelumab, an asthma treatment developed by Amgen and AstraZeneca, has been given priority review by officials to pave the way for a potential speedy approval of the experimental treatment.
The fastrack comes following the latest data from a phase three trial that showed it offered superiority across every primary and key secondary endpoint compared to placebo.
‘Severe asthma is a challenging, complex disease for physicians and millions of patients and has a high unmet medical need,’ said David Reese, executive vice president of R&D at Amgen.
The UK’s Competition & Markets Authority is considering launching an investigation into Motorola’s Airwave network used by emergency services.
The regulator is concerned that Motorola owns the critical network but it also supplying products and services to it. The CMA said it could consider asking Motorola to sell the network to alleviate its concerns.
‘Initial review of the evidence available indicates that the supply of the Airwave network in Great Britain is not working well, resulting in significant detriment to customers and the taxpayer,’ the CMA said.
Chinese firm LinkDoc Technology Group, which deals in medical data, has postponed its plans to launch an IPO in the US after China signalled it was cracking down on firms with overseas listings, according to Reuters.
It comes after the Chinese cybersecurity regulator launched an investigation into a number of companies, including many that have recently listed in the US including ride-hailing firm Didi and Full Truck Alliance. Didi has been particularly hard-hit by the review and seen its share price tank below its listing price, which is likely to encourage other Chinese firms to shelve their plans until there is more clarity.
Weight-loss app Noom is reported to be preparing to launch an IPO, according to reports from Reuters, as the company looks to capitalise on a surge in demand during the pandemic.
Noom is thought to be hoping to more than double its $3.7 billion valuation achieved during its last funding round in May, the report claimed, citing unnamed sources. The listing is not expected to happen until next year at the earliest.
Noom uses behavioural psychology and artificial intelligence to deliver a paid mobile app programme that help people improve their health and lose weight.
How to trade top US stocks
You can trade a variety of stocks with Forex.com in just four steps:
- Open a Forex.com account, or log-in if you’re already a customer.
- Search for the company you want to trade in our award-winning platform
- Choose your position and size, and your stop and limit levels
- Place the trade
Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.